SCHEMBL10243769

SCHEMBL10243769

O=C(c1ccc2cc[nH]c2c1)N1[C@@H]2CC[C@H]1C[C@@H](c1ccc(F)cc1)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.49
GHSR Q92847 4/20 0.48
SLC18A3 Q16572 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
ENPP2 Q13822 1/20 0.44
POLB P06746 1/20 0.42
KDM1A O60341 1/20 0.41
NR3C1 P04150 1/20 0.41
NR3C2 P08235 1/20 0.41
DRD2 P14416 3/20 0.41
DRD4 P21917 3/20 0.41
AHR P35869 1/20 0.41
CPS1 P31327 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
HTR1A P08908 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17350911 1.00 ESR1 (0.49) ESR1GHSRSLC18A3SIGMAR1KDM4E
SCHEMBL17350595 0.92 NPC1 (0.48) ESR1GHSRSLC18A3SIGMAR1POLB
SCHEMBL10243905 0.92 NPC1 (0.48) ESR1GHSRSLC18A3SIGMAR1POLB
SCHEMBL17350984 0.83 POLB (0.57) SLC18A3SIGMAR1KDM4EALDH1A1POLB
SCHEMBL10243883 0.83 POLB (0.57) SLC18A3SIGMAR1KDM4EALDH1A1POLB
SCHEMBL17350905 0.81 HSD11B1 (0.51) SLC18A3SIGMAR1KDM4EALDH1A1POLB
SCHEMBL10243989 0.81 HSD11B1 (0.51) SLC18A3SIGMAR1KDM4EALDH1A1POLB
SCHEMBL17350840 0.80 HSP90AA1 (0.47) SLC18A3SIGMAR1ALDH1A1HPGDPOLB
SCHEMBL10243810 0.80 HSP90AA1 (0.47) SLC18A3SIGMAR1ALDH1A1HPGDPOLB
SCHEMBL17350637 0.79 HSD11B1 (0.42) SLC18A3SIGMAR1POLBKDM1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318403-B1 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INT (DE) 2015-12-23 EP disclosed
US-20120115853-A1 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115853-A1 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use HSD11B1, HSD11B2, HSD17B1 ESR1 2982/4885GHSR 542/4885SLC18A3 3630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.